Panacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its bivalent oral polio vaccine (bOPV) worth approximately US$ 14.95 million (Rs 127 crore) in CY2025. The company recently posted a profit of Rs 4.8 crore, marking a strong recovery after three-quarters of losses.
